Status:
COMPLETED
GDF-8 Levels in ICSI Cycles
Lead Sponsor:
University of Alexandria
Conditions:
Infertility
Eligibility:
FEMALE
20-35 years
Phase:
NA
Brief Summary
The aim of this study is to investigate the role of GDF-8 in regulating progesterone levels during controlled ovarian stimulation in patients undergoing ICSI-ET and to evaluate its effects on pregnanc...
Eligibility Criteria
Inclusion
- The study population included women who underwent their first ICSI-ET cycles due to male and/or tubal factors or unexplained infertility, aged 20-35 years, whose BMI ranged from 19-29.9 kg/m2, with regular menstrual cycles
Exclusion
- women with PCOS, couples with azoospermic husbands, women with poor ovarian reserve testing (AMH \< 1.2 ng/dl and/or AFC \< 5), women diagnosed with endometriosis, and women with medical comorbidities such as thyroid disorders, DM, hyperprolactinemia, etc.
Key Trial Info
Start Date :
May 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2024
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT06529627
Start Date
May 1 2023
End Date
January 31 2024
Last Update
July 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shatby maternity university hospital
Alexandria, Egypt, 03312